The Food and Drug Administration (FDA) may approve birth control pills over-the-counter by the summer, but they expressed hesitation due to concerns over errors in submitted data on the drug’s safety.
An advisory committee to the FDA met Tuesday to make a recommendation on whether a historic approval of over-the-counter birth control drugs is safe for consumers. HRA Pharma requested its contraceptive drug, Opill, generically known as norgestrel, to be made available over-the-counter weeks after the Supreme Court overturned Roe v. Wade.
However, the agency expressed worries that access to the drug without a prescription may lead to increased errors in usage, according to a public briefing of Tuesday’s meeting.